In the BioHarmony Drug Report Database

"Preview" Icon

Lomefloxacin

Maxaquin, Quinsair (lomefloxacin) is a small molecule pharmaceutical. Lomefloxacin was first approved as Maxaquin on 1992-02-21. It is used to treat bronchitis, escherichia coli infections, klebsiella infections, proteus infections, and pseudomonas infections amongst others in the USA. It has been approved in Europe to treat cystic fibrosis and respiratory tract infections.

 

Trade Name

 

Quinsair
 

Common Name

 

lomefloxacin
 

ChEMBL ID

 

CHEMBL561
 

Indication

 

bronchitis, cystic fibrosis, escherichia coli infections, klebsiella infections, proteus infections, pseudomonas infections, respiratory tract infections, staphylococcal infections, streptococcal infections, urinary tract infections
 

Drug Class

 

Antibacterials (quinolone derivatives)

Image (chem structure or protein)

Lomefloxacin structure rendering